Wellgen joins the Tainan National Anti-Cancer Team to build a healthier Taiwan

Wellgen Medical officially joined the Tainan National Anti-Cancer Team, a collaborative alliance formed by five major hospitals in Tainan alongside several biotechnology companies. The initiative responds to President Lai Ching-te's National Cancer Prevention and Control Program, aiming to integrate medical and technological strengths to advance early cancer detection and clinical diagnostics.

Through its self-developed Cytology Tomography Scan technology, combined with high-resolution imaging and AI analytical capabilities, Wellgen assists clinicians in precisely interpreting cellular variations, offering frontline medical teams a more efficient and reliable diagnostic tool for cancer screening.

By contributing its imaging and AI expertise to this cross-sector alliance, Wellgen reinforces its role in supporting Taiwan's national anti-cancer effort. This collaboration reflects Wellgen's continued commitment to "AI-Assisted Diagnosis," extending its impact beyond individual clinical applications toward a broader, nationwide mission of building a healthier, more sustainable Taiwan.